Proteomic Analyses Identify Therapeutic Targets in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the fourth cause of cancer-related mortality worldwide. While many targeted therapies have been developed, the majority of HCC tumors do not harbor clinically actionable mutations. Protein-level aberrations, especially those not evident at the genomic level, present...

Descripción completa

Detalles Bibliográficos
Autores principales: Elmas, Abdulkadir, Lujambio, Amaia, Huang, Kuan-lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006883/
https://www.ncbi.nlm.nih.gov/pubmed/35433463
http://dx.doi.org/10.3389/fonc.2022.814120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006883/
https://www.ncbi.nlm.nih.gov/pubmed/35433463
http://dx.doi.org/10.3389/fonc.2022.814120

Ejemplares similares